Methotrexate, Leflunomide Linked to Adverse Pregnancy Outcomes in RA

Receiving methotrexate and leflunomide within the 3 months prior to conception was linked to an increased rate of adverse pregnancy outcomes.

Related Keywords

South Korea ,Korea , ,Korean National Health Insurance ,